Company Description

General Proximity is a breakthrough biotech platform company that has developed the proprietary OmniTAC platform to pioneer the next generation of induced proximity medicines, targeting undruggable proteins associated with cancer, cardiometabolic disease, neurodegeneration, and longevity.